US$ 20.61
glp-1 agonist therapy consultation preparation What to say when requesting options: guide to getting your prescription GLP-1 Weight Loss Medications |
Description
Pediatrics , 155(4), e2024068119

Incretin pharmacology: a review of the incretin effect and current incretin-based therapies

Publication numbers remained modest in the early decades but began to rise after the introduction of exenatide and liraglutide

Dual GLP-1/glucagon receptor agonists additionally engage pathways that increase energy expenditure and fat oxidation, potentially counteracting metabolic adaptations that limit sustained weight loss

Dahl D, Onishi Y, Norwood P, Huh R, Bray R, Patel H, Rodriguez A
